Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference13%
- Check20 days agoChange DetectedUpdate: revision version bumped from v3.0.2 to v3.1.0, indicating a new release. No other substantive content changes were detected.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2. The old revision line and the 'Back to Top' element were removed.SummaryDifference0.8%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.8%
- Check48 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference7%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.